Erasca Company

Erasca develops oncology drugs intended to provide precision oncology options. The company's drugs are being developed through multiple discovery programs for undisclosed targets that are biological drivers of cancer and are pursuing additional opportunities for pipeline expansion through academic and biopharmaceutical collaborations, providing patients with new potential solutions to not just treat but cure cancer. It was founded in 2018 and headquartered in San Diego, California.
Technology: Biotechnology, Life Science
Industry: Early Drug Development
Headquarters: San Diego, California, United States
Founded Date: 2018-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 12
Total Funding: 300000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-08-31
Last Funding Type: Series B

Visit Website
info@erasca.com
Register and Claim Ownership